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Abstract
Tinnitus is a disturbing noise that is heard without any hearing stimulus, affects the quality
of life of the individual, and leads to psychosocial problems. Its prevalence characteristically
increases with aging. It is seen in 33% of the general population. Pathophysiology of tinnitus
known to accompany nearly all disorders in auditory system has not been fully understood;
therefore, there are some difficulties in evaluation and treatment thereof. Despite the restric-
tive factors of tinnitus treatment, progress in auditory neuroscience provides a positive view
of tinnitus treatment. Transcranial magnetic stimulation (TMS) is a method based on the
stimulation of neuronal tissue without depending on the transfer of electrical current by
means of electrodes or the skin. TMS is used in the treatment of various diseases with
developing neuroscience. In the recent years, the number of studies on TMS application
with repetitive low frequency for the treatment of tinnitus has increased, and most of these
studies have given successful results. Repetitive use of TMS in tinnitus is very novel;
however, it is commonly used in psychiatric disorders, especially in the treatment of drug-
resistant depression. The chapter shows that low-frequency repetitive TMS (rTMS) is useful
in the treatment of chronic tinnitus.
Keywords: tinnitus, transcranial magnetic stimulation, tinnitus handicap inventory,
rTMS, THI
1. Introduction
1.1. Tinnitus
Along with the development of technology and urbanization, there are some additional bur-
dens along with the convenience of our lives. Increasing traffic with urbanization, increasing
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use of mobile phones from early ages, and listening to loud music with headphones cause our
life to become more loud and tense.
Tinnitus is a symptom thought to be heard without a voice stimulus. The presence of tinnitus
also affects the quality of life of individuals and causes psychosocial problems. It is characteristic
that it becomes more common with aging. It is present in one third of the general population [1].
Forty-sixty million people in the United States have a tinnitus on one occasion, and according
to most of them, this does not pose any problem for any treatment. Only 1–5% of individuals
with tinnitus have severe and uncomfortable ear tinnitus [2, 3].
Tinnitus occurs with 30-dB hearing loss at the rate of 75%. As the hearing level decreases, its
incidence increases. It was detected that exposure to high sound or noise increases tinnitus
prevalence.
Pathophysiology of tinnitus known to accompany nearly all disorders in auditory system has
not been fully understood; therefore, there are some difficulties in evaluation and treatment
thereof. Tinnitus is still a subject of research on neurotology. However, the etiology and
physiopathology are not well known. Therefore, tinnitus treatment has not yet been clarified.
Tinnitus can also have a large economic effect. The lack of standardization of tinnitus diagnosis
and treatment management increases the cost of health care [4]. Tinnitus reduces the concen-
tration of the person, restricts their participation in professional activities, thus reducing the
work efficiency of the person [5–7].
Despite the restrictive factors of tinnitus treatment, progress in auditory neuroscience provides
a positive view of tinnitus treatment.
Transcranial magnetic stimulation (TMS) is a method based on the stimulation of neuronal tissue
without depending on the transfer of electrical current by means of electrodes or the skin. TMS is
used in the treatment of various diseases with developing neuroscience. Good news is coming
from recent studies on TMS application with repetitive low frequency in tinnitus treatment. TMS
inhibits abnormal cortical activities in the affected area. Tinnitus treatment is applied to auditory
cortex. Positive results have been revealed during the studies [8, 9].
This chapter is devoted to evaluate the effects of transcranial magnetic stimulation (TMS) on
the treatment of subjective tinnitus.
1.1.1. Tinnitus pathophysiology
The auditory system is a complex system and contains a large number of central nuclei that
provide the cortical organ peripheral fibers in the spiral laminates, multiple afferent and
efferent delivery channels, and complex integration in the upper centers of the central nervous
system [10–12]. The pathologies that occur anywhere in these regions cause an increase in the
perception of sound through unknown mechanisms. Researchers have tried to explain the
formation and perception of tinnitus with many different mechanisms.
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• Damage to inner and outer hair cells
• Ion imbalance in the cochlea
• Dysfunction in the cochlear neurotransmitter system
• Heterogeneous activation in the cochlear efferent system
• Heterogeneous activation in type I and II cochlear afferents
• Cross links between the eight nerve fibrils [13]
Every nerve fiber has an electrical discharge even at rest. This is called the spontaneous activity
of that nerve. There is an increase in spontaneous activity in patients with tinnitus. All of the
assumptions put forward to explain the pathogenesis of tinnitus are based on this spontaneous
activity increase [1, 14]. Recent studies suggest that tinnitus is an event based on hyperactivity
of the auditory system, which is temporarily adjusted by TMS [15]. Theories about pathophys-
iology of tinnitus can be grouped as follows:
According to Moller, some of the adjacent nerve fibers are damaged for some reason, resulting in
artificial synapse between the nerve fibers, and these synapses between the fibers cause patho-
logical transmissions. This results in increased spontaneous activity and tinnitus [1, 14, 16].
Jastreboff and Hazell note that when the temporal cortex is reduced in hearing impulses, there
is an increase in neuronal sensitivity in the subcortical centers. For this reason, a tinnitus
patient with normal hearing is thought to be associated with subcortical centers, which we
hear as weak voices in auditory cues (e.g., in quiet rooms) [13].
Tonndorf states that tinnitus can originate from all levels of the auditory system. If tinnitus is
acoustically masked, it is originated from peripheral auditory system, whereas if tinnitus
masking is not present, it is originated from central auditory system. There is a chemical
imbalance between the tinnitus cell membrane and the stereocilia. This leads to hyperactive
flickering hair or hyperactive nerve fibers. For this reason, even very low spontaneous activi-
ties are perceived by these shaky hair or nerve fibers. This condition could be likened to
postamputation phenomenon [1, 14, 17, 18]. In 1965, Melzack and Wall proposed the door
control theory for chronic pain. Tonndorf proposed this theory for tinnitus [19, 20]. The balance
of the impulse that comes from the afferent inner hair cell and the outer hair cell to brainstem,
respectively, seems to shift unilaterally when one or more of the hair cell’s subsystem is
damaged. Tonndorf suggests that this imbalance of warning may cause tinnitus.
Salvi and Ahroon reported that spontaneous neural activity in the area of the cochlea lesion
leads to tinnitus, that acoustic trauma affects cochlea when exposed to noise, and that sponta-
neous discharges more frequently occur in the high-frequency region of cochlea than in other
regions. This increase in spontaneous activity level is expressed as tinnitus [21, 22].
According to Kiang, there are abnormal stereocilia. In the transition between normal and
abnormal stereocilia, the suppression of normal cells is lost. This leads to increased spontane-
ous activity. This leads to tinnitus [14]. Sellick et al. argued that the displacement of the
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membrane towards to scala tympani causes hyperactivity. It is thought that tinnitus occurs in
this way [14].
In 1984, Eggermont assumed that there was hypersensitivity in stereocilia. This may be due to
a reduction in the inhibition applied by the central route. Thus, nerve fibers perceive sounds
that would normally not be heard. That said, tinnitus may be the cause [1, 14, 23]. In addition,
Eggermont suggested in 1990 that the balance between stereocilia activities and nerve fiber
activities could have contributed to tinnitus [24].
Although inner ear damage occurs and the eighth cranial nerve is cut, the continuation of
tinnitus in some patients supports the concept of ‘central tinnitus.’ Peripheral tinnitus may be
localized in one or two ears, while central tinnitus is usually not localized at one point. The
major causes of central tinnitus are occupied lesions, inflammations, and vascular anomalies,
and often masking does not succeed. Auditory brainstem response (ABR) is helpful in the
diagnosis of central tinnitus [25].
Tinnitus can be defined as objective or subjective. Objective tinnitus can be detected by another
person or physician.
Objective tinnitus usually has a pulsatile or rhythmic quality. Table 1 lists common causes of
objective tinnitus.
Objective tinnitus can be caused by auditory and nonauditory disorders such as Ménière’s
disease, Eustachian tube disorders, intracranial hypertension, middle ear diseases etc [26].
Objective tinnitus treatment depends on the underlying disease. This subject will not be discussed
in this chapter.
Pulsatile
• Venous etiologies
• Venous hum
• Hypertension
• Pseudotumor cerebri
• Sigmoid sinus and jugular bulb anomalies
• Arterial etiologies
• Paraganglioma (glomus tympanicum or jugulare)
• Persistent stapedial artery
• Intratympanic carotid artery
• Arteriovenous fistula or malformation
• Increased cardiac output (pregnancy and thyrotoxicosis)
• Carotid artery stenosis
• Vascular compression of cranial nerve VII
• Intraosseous (Paget disease and otosclerosis)
• Tensor tympani or stapedial muscle myoclonus
• Palatal myoclonus
Nonpulsatile
• Patulous Eustachian tube
• Spontaneous otoacoustic emission
• Idiopathic stapedial muscle spasm
Table 1. Objective tinnitus subtypes.
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1.1.2. Subjective tinnitus
The most common form of tinnitus is subjective tinnitus. Unlike objective tinnitus, subjective
tinnitus cannot be heard by anyone else. The prevalence of subjective tinnitus is estimated
between 8% and 30% and tinnitus should be defined according to the population of the study,
the severity of tinnitus, and the evaluation of the methodology [2, 27, 28].
The most important cause of tinnitus is exposure to sound. The main problem in most patients
is unknown [29].
Subjective tinnitus most commonly occurs due to sensorineural hearing loss (SNHL), which is
caused by the presbycusis and acoustic trauma, conductive hearing loss, endolymphatic
hydrops, and cerebellopontine angle neoplasia, which are more rare causes of tinnitus. Subjec-
tive tinnitus is the most common form that affects adults, and it is the focus of this chapter.
Tinnitus subtype classification schemes can be useful to identify forms of tinnitus that are
responsive to specific targeted treatment programs. Table 2 lists common causes of subjective
tinnitus.
1.1.2.1. Hearing loss
Urbanization and industrialization are accompanied by increased hearing loss due to noise.
Noise-induced hearing loss (NIHL) is a significant and increasing health problem. Unfortunately,
• Otologic factors
• Presbycusis
• Noise-induced hearing loss
• High-frequency hearing loss
• Outer hair cell dysfunction
• Ménière’s disease
• Somatic tinnitus
• Temporomandibular joint syndrome
• Typewriter tinnitus
• Psychological factors
• Anxiety
• Depression
• Pharmacological factors
• Aspirin compounds
• Nonsteroidal anti-inflammatory drugs
• Aminoglycosides
• Heavy metals
• Metabolic factors
• Hypothyroidism
• Hyperthyroidism
• Hyperlipidemia
• Vitamin deficiency
• Neurologic abnormalities
• Multiple sclerosis
• Meningitic effects
• Skull fracture or closed head trauma
Table 2. Subjective tinnitus subtypes.
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many people do not care about industrial noise, fire alarms, listening to music loudly and other
noises, or how unaware they are. According to a study conducted, 61% of people who went to
the concert found hearing loss and temporary ringing of ears after the concert [30]. The preva-
lence of chronic tinnitus associated with NIHL is 50–70% [31].
Presbycusis is a sensorineural hearing loss that occurs with aging. Personal and environmental
factors play a role in the development of presbycusis, but it mainly involves complex genetic
factors. The best-known environmental factor is noise, and hearing is better protected in
elderly people who are not exposed to high sound.
1.1.2.2. Somatic tinnitus
Somatic tinnitus can be modulated by maneuvers or stimulation of the head and neck region.
Patients with temporomandibular joint (TMJ) disorder had higher incidence of tinnitus com-
pared to control groups [32]. When tinnitus occurs in association with disorders of the head
and neck such as TMJ dysfunction, unilateral facial pain, otalgia, and occipital or temporal
headache, successful tinnitus alleviation may be possible using interventions that target the
somatic dysfunction [17].
1.1.2.3. Typewriter tinnitus
This type of tinnitus may be confused with tinnitus that arises from a muscular source, such as
spasm of the tensor tympani or stapedius muscles, or palatal myoclonus. Typewriter tinnitus is
defined, as its name implies, by the characteristic sensation of a staccato quality to tinnitus,
similar to a typewriter tapping, popcorn popping, or Morse code signaling. Typewriter tinni-
tus is distinct from these somatic sources, as illustrated by a patient with typewriter tinnitus
that failed to respond to tensor tympani and stapedius resection [33].
1.1.2.4. Psychological factors
Emotional distress and disturbance of sleep are often associated with severe tinnitus. Stress often
increases the perception of tinnitus severity, and depression frequently accentuates the com-
plaint. In some cases, tinnitus itself may be the cause of the psychological disorder. Depression
is common in patients with tinnitus, but it is not always clear whether depression is primary or
secondary.
1.1.2.5. Pharmacological factors
The pharmaceutical industry has developed in the last 50 years. Despite the developing world,
rational drug use is not yet fully established. Almost every medication can be considered as a
possible cause for tinnitus. The main ones responsible are listed in Table 3.
The aim of tinnitus treatment is to reduce or, if it is possible, to eliminate the voice that disturbs
the patients [22]. Symptomatic treatment options are important because etiologic causes are
detected in 5% of the cases [34, 35].
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1.1.3. Examination and tests
In order to be able to treat patients with tinnitus or to improve the effectiveness of treatment,
detailed evaluation of the patients and the investigation of the etiology are required. We have not
created a successful standard protocol for evaluating tinnitus until now. Assessment of tinnitus is
medically and audiologically interpreted and is used to make individual plans for tinnitus
treatment [36]. The transactions to be made in the evaluation can be listed as follows:
1. History: the major importance in the evaluation of tinnitus patients is anamnesis [37, 38]. A
detailed history of the patient should be taken. Age at which tinnitus began, audiovestibular
symptoms (hearing loss and dizziness), the nature of tinnitus (intensity and frequency) and
daytime changes, family history, history of exposure to noise, smoking, alcohol use, systemic
diseases, head trauma, ototoxic drug use, epilepsy, otosclerosis, and past meningitis must be
questioned.
2. Physical examination: after obtaining a complete history of the patient with tinnitus,
clinical management should begin with a general medical evaluation followed by a com-
plete head and neck examination. All tinnitus patients should undergo neurological exam-
ination including a detailed ENT examination, temporomandibular joint examination and
diapason tests, general medical evaluation, and cranial nerve examination [10, 11].
3. Audiologic evaluation: pure audio audiometry, speech audiometry, percentage of speech
discrimination, disturbing auditory height, impedance metric evaluation, otoacoustic
emission (OAE), and auditory brainstem response (ABR) can be performed [39–42].
Nonsteroidal anti-inflammatory drugs
• Ibuprofen
• Indomethacin
• Naproxen
• Phenylbutazone
• Sulindak
Amikacin
Aminoglycoside antibiotics
• Streptomycin
• Neomycin
• Gentamycin
• Tobramycin
Aspirin and aspirin-containing compounds
• Darvon
• Percodan
• Ecotrin
• Bufferin
Heterocyclic antidepressants
• Nortriptyline
• Amitriptyline
• Trazodone
• Amoxapine
• Doxepin
• Trimipramine
Table 3. Medications that cause tinnitus.
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4. Laboratory tests: complete blood cell count and extensive biochemical examinations
should be performed routinely. If the patient is suspected of any metabolic or medical
condition, more detailed examination should be performed.
5. Radiological evaluation: temporomandibular joint disease should be excluded by radio-
logical evaluation. In patients with unilateral hearing loss, radiological evaluation may be
needed to exclude posterior fossa tumors. Computed tomography (CT) is sufficient in the
evaluation of most tumors and anomalies. MRI should be performed to exclude vestibular
schwannoma or other cerebellopontine angle sister neoplasms if there is a clinical suspi-
cion for patients with nonpulsatile tinnitus [43].
1.1.4. Tinnitus and audiologic findings
1.1.4.1. Pure sound audiogram
It has been reported that 13% of tinnitus cases have transmission-type hearing loss and 39%
have sensorineural-type hearing loss. Hearing loss was more frequent in the high-frequency
range of the sensorineural hearing loss group [37].
1.1.4.2. Otoacoustic emissions (OAE)
It is thought that OAE is a special evaluation method for cochlear auditory dysfunction in the
light of the studies performed and objectively confirms cochlear dysfunction in patients with
normal audiogram and tinnitus complaints [44].
Tyler and his colleagues reported that only one of their 25 patients had spontaneous OAEs and
found no connection between spontaneous OAEs and tinnitus curtain or severity [45]. Penner
and Burns investigated whether the SOAE measurement would be of an objective value in
terms of tinnitus correlation, but they could not find a relationship [46]. As a result of some
studies on the relationship between SOAE and tinnitus, only a small group of patients has been
identified [45, 47]. Studies are underway to investigate the relationship between distortion
product otoacoustic emissions (DPOAE) and tinnitus. In these studies, it was revealed that
there is a significant relationship between the frequency of tinnitus emergence and DPOAE
responses [48].
1.1.4.3. Auditory brainstem response (ABR)
It is a diagnostic measure to help determine the type of tinnitus. There was no difference in the
ABR test of the tinnitus patient group in the study of all normal hearing individuals [49].
1.1.5. Evaluation of findings
There are many questionnaires to evaluate the severity of tinnitus and its negative impact on
the patient. A standard assessment is needed to document and report the results of clinical
trials. Tinnitus, which is defined and graded on this scale, is standardized, and the common
denominator in the treatment approach is unified.
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Various methods can be used to evaluate the findings of the patients. Tinnitus handicap inven-
tory (THI) is an easily applicable test that is not affected by age, sex, and hearing loss of the
patient [50]. A confidence interval of 95% for THI is 20 points, which suggests that a difference in
scores of 20 points or greater represents a statistically and clinically significant change.
1.1.6. Tinnitus treatment strategies
Tinnitus is a complex, multifactorial problem with many potential options that can help the
patient cope with the condition. You cannot cure tinnitus without understanding tinnitus. We
try to approach some treatment modalities for subjective tinnitus after excluding organic
causes. Currently, there are some treatment options for patients with tinnitus. Based on the
2014 tinnitus guidelines, the treatment options are shown in Table 4 [26].
1.1.6.1. Education and counseling
Patient education should instead emphasize that tinnitus itself is a symptom and not a dan-
gerous disease, and a comprehensive assessment can exclude any associated medical condi-
tions that require prompt treatment.
When counseling the patient, it is absolutely necessary to explain the importance of avoiding
noise. The relationship between noise and tinnitus should be reminded.
1.1.6.2. Sound therapy
Acoustic stimulation has an important place in the treatment of tinnitus. Sound therapy can
decrease the subjective loudness of tinnitus, which can significantly decrease the annoyance,
but this may require weeks to months of daily application. Acoustic stimulation can be
achieved in many ways. Masking of tinnitus is based on the principle of suppressing the inner
voice from the outside. Masking can be applied with various methods such as hearing aids,
tinnitus instruments, and maskers.
A hearing aid is a simple method that can be used in patients with hearing loss who have
tinnitus. The hearing aid reduces tinnitus by masking the annoying sound the patient per-
ceives by increasing the volume of the sound coming from the outside.
The tinnitus instrument is a device that includes both the properties of the hearing aid and the
masking device. Hearing aid input and masking device input are independent of each other,
• Education and counseling
• Sound therapy
• Cognitive behavioral therapy
• Medical therapy
• Dietary supplements
• Acupuncture
• Transcranial magnetic stimulation
Table 4. Tinnitus treatment options.
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which can only increase the masking volume at night or in quiet environments where tinnitus
is intensified. Masking is only a substitute solution for tinnitus and not a cure.
1.1.6.3. Cognitive behavioral therapy (CBT)
Cognitive behavioral therapy has been shown to be effective in the treatment of tinnitus-
related disorders. In many patients, stress or depression is a major factor in the intensity and
severity of their complaints. Cognitive behavioral therapy (CBT) is a psychotherapy based on
identification and modification of maladaptive behaviors using therapist-mediated cognitive
restructuring techniques. Andersson and Lyttkens analyzed 18 studies of psychological treat-
ments for tinnitus and concluded that CBT was more effective than behavioral treatments
alone [51].
1.1.6.4. Medical therapy
With the development of the pharmaceutical industry, in the last 50 years, pharmacological
treatment for tinnitus has come to the forefront. Drugs used in the treatment of tinnitus are
used as useful medicines in terms of improving the emotional state of the patient, reducing
anxiety, and improving sleep. Anesthetics (lidocaine, tocainide, and mexiletine), anticonvul-
sants (carbamazepine and gabapentin), and tranquilizers (diazepam, clonazepam, and oxaze-
pam) have been investigated as tinnitus treatments.
At this time, there are no medications approved by the US Food and Drug Administration
(FDA) for treatment of tinnitus.
1.1.6.5. Dietary supplements
Tinnitus appears to be a disease that is unlikely to be treated for most patients. This situation
forces the physicians and patients to try other treatment methods. Ginkgo biloba and melatonin
are the products of recent use that is increasing. G. biloba extract contains multiple compounds
with vasotropic, potential neuroprotective, and antioxidant effects. Several other dietary sup-
plements have been used for tinnitus, including lipoflavonoids, garlic, homeopathy, traditional
Chinese/Korean herbal medicine, honeybee larvae, and other various vitamins and minerals.
Evidence for efficacy of these therapies for tinnitus does not exist.
Further study is needed to investigate the side effects that may occur in the use of G. biloba,
melatonin, or dietary supplements, as well as the use of such products in the treatment of
patients with primary tinnitus.
1.1.6.6. Acupuncture
Acupuncture is a form of alternative medicine in which thin needles are inserted into the body.
It is a key component of traditional Chinese medicine. The role of acupuncture in tinnitus
patients is still controversial. Although unblinded studies have suggested positive results, they
have not been reproduced in blinded studies [52]. There is general consensus that acupuncture
is a relatively safe treatment when administered by well-trained and experienced practitioners
[53–58].
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The objective of the current chapter is to evaluate the effect of TMS on the treatment of
subjective tinnitus, so you can find detailed information about other treatments of tinnitus in
the literature.
2. Transcranial magnetic stimulation
Transcranial magnetic stimulation (TMS) is a method based on the stimulation of neuronal
tissue without depending on the transfer of electrical current by means of electrodes or the
skin. Magnetic stimulation causes transient disturbances of neural activity in different regions
of the cortex. The depth of penetration is limited to less than 2 cm [59]. With stimulation, it
forms a temporary lesion in the region. This reversible lesion allows the investigator to provide
information about whether the cortical region contributes to a particular perception or behav-
ior [60]. To better understand motor responses and corticospinal mechanisms to deep brain
stimuli in Parkinson’s patients [61, 62], phantom muscle contractions were used for cortical
silent period studies [63]. In 1980, Merton and Morton have shown that motor neurons can be
stimulated by a single, high-voltage, short-duration electrical stimulus applied to a rigid scalp
with an electrical stimulator [64]. In 1985, Barker and colleagues began to use transcranial
magnetic stimulation, which is transmitted through tissues like the same electrical stimulator
and applied with a magnetic stimulator that stimulates the cerebral motor cortex and is more
painless [65]. Since then, transcranial magnetic stimulation became widely used in areas such
as clinical neurophysiology, neurology, and psychiatry. In the following years, transcranial
magnetic stimulation became widely used in the evaluation of many other cerebral functions
as well as studies in the developing peripheral nerves and muscles that stimulate magnetic
stimulation producing coils to stimulate a small area of the cortex [66–68]. Today, advanced
TMS machines can deliver up to 60 stimuli.
The magnetic field affected by a single pulse is measured for milliseconds for a short time.
Repeated stimuli cause superficial cortex to change from a few seconds to a few minutes of
neuronal depolarization. Repeated stimuli produce different responses depending on the
frequency of the region. The application of repetitive stimuli is termed repetitive TMS (rTMS).
Low-frequency (<1 Hz) repetitive TMS decreases cortical excitability [69], whereas high-
frequency (5–20 Hz) repetitive TMS increases cortical excitability [70]. 1 Hz or slower is called
slow rTMS; faster than 1 Hz is called fast rTMS. In the practice of TMS, when the head piece
was placed on the scalp corresponding to the projection of the motor cortex and stimulated,
the opposite extremities were seen to move painlessly [65]. The diameter of the electrodes used
for magnetic stimulation is the most important factor affecting the magnetic field configura-
tion. Electrodes are divided into “circular” or “butterfly” type. Those in butterfly type are
called “double shape” or “eight shaped.” Their difference from the circular types is that the
maximum current intensity is below the center point. These electrodes are more suitable for
selective excitation by producing more localized currents [71, 72]. A magnetic exciter consists
of a high-capacity series capacitor and a copper winder. With the discharge of the capacitor, a
sudden and high-power (1–4.3 T) magnetic field exchange occurs around the coil. With this
effect, ion currents emerge in the neural tissues adjacent to the region where it is placed on the
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coil and stimulate the neural tissue. If enough magnitude and a rapidly changing magnetic
pulse are generated at a sufficient depth, this pulse will cause a secondary ion current in the
neuronal tissue [68]. This leads to depolarization of the membrane in the stimulated region of
the neuronal tissue. Magnetic stimulation reaches the neuronal tissue without being hindered
by intervening tissues such as skin and bone, which does not cause any obvious pain because it
does not stimulate the surrounding tissues [73].
The therapeutic response of magnetic stimulation has been observed to be more pronounced
with frequent repetitive stimulation (repetitive magnetic stimulation) and studies have shifted
to this direction. For this purpose, it was most commonly used in psychiatric disorders [74]. In
drug-resistant depressions, repetitive transcranial magnetic stimulation resulted in improve-
ments of 40–50% [75]. TMS has been studied and is still being studied in psychiatric disorders
such as schizophrenia, obsessive-compulsive disorder, posttraumatic stress disorder, and
mania even though it is not the same size as depression. TMS is one of the safest and painless
methods used in the evaluation of the nervous system and in the treatment of the mentioned
psychiatric disorders [76–79]. It is not recommended to be applied in patients who have clips
with neurosurgical operation and patients with heart pace because they can stimulate an
epileptic seizure on the stroke [80, 81]. Although the use of repetitive TMS (rTMS) in tinnitus
is very recent, there are many studies on the efficacy [8, 9, 82]. TMS has opened a new vision
into investigating the causes and associations of tinnitus-related cortical activity, and it may
provide an effective tinnitus therapy for some patients.
Imaging methods can show asymmetric metabolic activity in the hearing cortex of patients
with tinnitus. Functional magnetic resonance imaging and fluorodeoxyglucose positron emis-
sion tomography provide it [83, 84]. The fact that rTMS has an inhibitory effect on the area it is
applied to suggests that it may also be effective in the treatment of tinnitus [8, 9, 85].
2.1. TMS in the treatment of tinnitus
Tinnitus is still a subject of research on neurotology; however, recent studies in literature are
not sufficient enough to enlighten the etiology or pathophysiology of tinnitus, and because of
this uncertainty, treatment options are limited. Success rate of medical treatment of tinnitus
according to the literature is between 30 and 80%, and most of these studies underline the
effectiveness of placebo [86, 87]. TMS application for tinnitus treatment is a relatively new
subject, studies are providing very little information, but the results seem promising.
It is important to determine the frequency and loudness of tinnitus because these are correlated
with affects of tinnitus on the patients’ life [88, 89]. Tinnitus is present in 65% of the population
with hearing problems, and tinnitus in 50% of them is a serious problem [90]. According to one
study, tinnitus is a serious problem for 2.6% of the local population [91].
The probability of tinnitus is increasing in patients with hearing loss [92]. If external hair cell
damage is not up to 30%, the hearing thresholds do not get affected. This could explain
tinnitus in patients who do not have hearing loss [20]. The loudness and frequency of tinnitus
must be determined for rehabilitation [93]. In Yilmaz et al.’s study, the mean (SD) scores in the
TMS group before the treatment was 7.069 (1.42) and 7.073 (1.52) points in the placebo group,
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and these results were higher when compared with the literature [44, 50]. In general literature,
THI is used in the evaluation of tinnitus before and after the treatment [16, 50, 94–96].
Detection of the frequency at which tinnitus is occurring is almost always difficult [93]. It has
been determined that the frequency of tinnitus changes in 60% of cases according to the studies
[97]. According to general opinion, tinnitus frequency is above 2000 Hz and mostly at 4000 Hz
[86]. In Yilmaz et al.’s study [50], the mean (SD) frequency of tinnitus in the TMS group before
the treatment was 7234 (2818) and 5626 (2494) Hz in the placebo group. The mean frequency of
tinnitus of all patients before the treatment was 6450 Hz.
Good news is coming from recent studies on TMS application with repetitive low frequency in
tinnitus treatment. TMS inhibits abnormal cortical activities in the affected area. Tinnitus
treatment is applied to the auditory cortex. Positive results have been revealed during the
studies [8, 9]. Animal models and functional human brain imaging studies, which were
designed to investigate the pathophysiology of tinnitus, suggest that there is increased signals
and activity in the central auditory pathways and also nonauditory brain areas [98].
Many studies suggested radiological findings were used to determine the coil positioning in
order to increase efficacy. One suggested method is using positron emission tomography (PET)
to determine the hyperactive auditory cortex [99]. Electroencephalography (EEG) also
suggested resting state auditory gamma activity as a marker for tinnitus [100]. However, no
association was demonstrated between tinnitus loudness and auditory gamma band. Also
Langguth’s study showed no superiority of EEG over PET, and this study could not demon-
strate PET-guided coil positioning’s superiority over standard-positioned coils [101]. Anatom-
ical magnetic resonance imaging (MRI) is used as a guide in recent studies to position the coil
to the primary auditory cortex [102–104]. Functional MRI activity could demonstrate tinnitus-
matched sounds’ effect on specific cortex areas, but evidence of this kind of navigation for
tinnitus is not available [105]. Noh et al.’s recent study showed that there was no significant
difference between EEG-guided or neuronavigation-guided coil placement [106].
Functional magnetic resonance imaging and F-18 fluorodeoxyglucose positron emission
tomography have shown asymmetric metabolic activity in the hearing cortex of patients with
unilateral or bilateral tinnitus [83]. Coactivation of prefrontal areas was detected in imaging
studies. This may be related to the affective compacts of tinnitus [107–109]. Frontothalamic
gating system may be formed by limbic and paralimbic structures for tinnitus [110]. James
et al.’s study demonstrated with functional MRI that left superior dorsolateral prefrontal
cortex had a greater role in predicting tinnitus awareness [111]. Combined prefrontal and
temporal cortex rTMS was found to be more effective than temporal cortex rTMS alone
[101, 112–114].
rTMS’s antiapoptotic mechanism was demonstrated in Yoon et al.’s recent animal model [115].
Repeated stimulation induces neuroplastic changes. Single session effects seem to be short and
immediate, and daily treatment over 4 weeks seem to have longer results that last over months
to years [116–118].
Kleinjung et al. reported that, after rTMS application to the patients with chronic tinnitus, the
mean score of tinnitus decreased at the rate of 7.5% [8]. De Ridder and colleagues found
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positive results in half of the patients with rTMS in unilateral tinnitus treatment in 114 patients
[9]. Kleinjung and colleagues found that application of low-frequency rTMS for 5 days had
significant effects on tinnitus treatment [8]. In another study, 3 patients were treated with 1 Hz
rTMS (2000 stimulus/day) for 5 days and 2 of the patients had a positive result [99]. In
Langguth et al.’s study, 28 patients were treated with 1 Hz rTMS (2000 stimulus/day) for
10 days and 67.8% of the patients had a positive result [119]. Folmer et al.’s study demon-
strated that 1 Hz rTMS for chronic tinnitus is an effective treatment method. The application of
rTMS daily for 10 days had significantly better outcomes of chronic tinnitus patients [120].
In order to suppress tinnitus, various stimulation patterns have been reported as effective such
as 1 Hz, 10 Hz, and burst stimulation [82, 103, 121–124].
A new TMS protocol was introduced by Huang et al. in 2008 [125]: the protocol named theta
burst stimulation [TBS], which is a repeated application of triplets of 50 Hz pulses with 200 ms
(5 Hz; theta) pulse interval [125]. Huang et al. suggested that this protocol is superior to tonic
rTMS [125]. However, literature findings are controversial. De Riddler et al., Lorenz et al., and
Poreiz et al. showed the efficacy of TBS but Chung et al.’s and Plewnia et al.’s studies did not
find the same efficacy [103, 126–130]. Many studies showed low-frequency 1 Hz rTMS to be
effective for tinnitus. Khedr et al. suggested that 10 or 20 Hz stimulation could also be effective
[123]. James et al.’s study demonstrated that 1 Hz rTMS seemed to significantly decrease the
awareness, loudness, and annoyance of tinnitus, but 10 Hz stimulus seemed to decrease only
the awareness of tinnitus [111].
Kreuzer et al.’s study suggested that individualized rTMS sessions’ outcomes were better,
since tinnitus is a personal symptom and hard to generalize [131]. In Yilmaz et al.’s study,
THI score decreased by 8 points after the application of low-frequency rTMS, and also a
statistically significant decrease was observed in tinnitus loudness and subjective score after
the application of rTMS [50]. Park et al. studied the difference between 6000 pulse and 12,000
pulse rTMS to temporal and prefrontal cortex. Patients who received 12,000 pulses of rTMS
seemed to have better outcomes. This study seems to be the first in literature that underlines
the importance of pulse rate, at least 12,000 pulses of rTMS seems to achieve a favorable
outcome [132].
The chapter showed that low-frequency rTMS is useful in the treatment of chronic tinnitus.
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